These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19. Brubaker L; Mortus J; Cruz M; Trautner B; Loor M; Rosengart T J Am Coll Surg; 2021 Feb; 232(2):227-229. PubMed ID: 33246792 [No Abstract] [Full Text] [Related]
25. [Learning about anticoagulation with COVID-19]. Zarza J; Rodríguez V; Báez E An Sist Sanit Navar; 2021 Apr; 44(1):127-128. PubMed ID: 33853211 [No Abstract] [Full Text] [Related]
26. Continuation of therapeutic dose heparin for critically ill patients with COVID-19. Bradbury CA; Lawler PR; McVerry BJ; Zarychanski R; Intensive Care Med; 2023 Jul; 49(7):873-875. PubMed ID: 37256341 [No Abstract] [Full Text] [Related]
27. Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients. Bisso IC; Huespe I; Prado E; Garbarini M; López MS; Barrera L; Las Heras M; Sinner J; Martinuzzo M Clin Appl Thromb Hemost; 2022; 28():10760296221091213. PubMed ID: 35345901 [No Abstract] [Full Text] [Related]
28. Outcomes of Covid-19 organizing pneumonia in critically ill patients. Rocha AS; Meireles M; Vilaça H; Guimarães TC; Martins MD; Santos LR; Castro A; Mesquita M J Infect; 2021 Oct; 83(4):496-522. PubMed ID: 34217780 [No Abstract] [Full Text] [Related]
29. Major bleeding complications in critically ill patients with COVID-19 pneumonia. Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501 [TBL] [Abstract][Full Text] [Related]
30. Challenges Before Considering Full-Dose Anticoagulation in Noncritically Ill Patients With COVID-19. Agirbasli M J Am Coll Cardiol; 2023 Aug; 82(7):e57. PubMed ID: 37558379 [No Abstract] [Full Text] [Related]
31. When to use anticoagulation in COVID-19. Moll M; Connors JM Thromb Res; 2021 Aug; 204():136-137. PubMed ID: 34176588 [No Abstract] [Full Text] [Related]
33. Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation. Yan Y; Jiang X; Fu J; Huang J; Qiu Y; Ding D; Ge L; Zhang H; Huang L; Lu X; Hu Q J Infect; 2021 Apr; 82(4):84-123. PubMed ID: 33188798 [No Abstract] [Full Text] [Related]
34. Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation. Paparella D; Colucci M; Squiccimarro E; Raimondo P; De Palma F; Ranieri P; Mariggiò MA; Grasso S Thromb Res; 2020 Dec; 196():272-275. PubMed ID: 32942235 [No Abstract] [Full Text] [Related]
35. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F; Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170 [TBL] [Abstract][Full Text] [Related]
36. Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations. Flaczyk A; Rosovsky RP; Reed CT; Bankhead-Kendall BK; Bittner EA; Chang MG Crit Care; 2020 Sep; 24(1):559. PubMed ID: 32938471 [TBL] [Abstract][Full Text] [Related]
37. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease. Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555 [TBL] [Abstract][Full Text] [Related]
38. Critically Ill Hong W; Chen Q; Qian S; Basharat Z; Zimmer V; Wang Y; Zippi M; Pan J Front Cell Infect Microbiol; 2021; 11():550456. PubMed ID: 34327146 [TBL] [Abstract][Full Text] [Related]
39. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support. Donato AA Ann Intern Med; 2021 Dec; 174(12):JC134. PubMed ID: 34871053 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply. Rosas IO; Raby B; Tsai L N Engl J Med; 2021 Sep; 385(12):1149. PubMed ID: 34407336 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]